MoCA marketing

MoCA Cognition

Grâce à MoCA Cognition, nous continuons à traduire, adapter et héberger plusieurs versions du test MoCA de référence pour soutenir les soins de santé et la recherche dans le monde entier. Avec une équipe de neuroscientifiques, de cliniciens, de data scientists et d'ingénieurs, nous développons la prochaine génération de solutions d'évaluation cognitive basées sur l'IA et les technologies mobiles. Notre clinique de la mémoire affiliée au MoCA et nos collaborations universitaires mondiales fournissent des informations uniques pour répondre aux besoins croissants en matière de soins de santé et de dépistage au niveau de la population.

Nos outils de pointe sont essentiels au diagnostic précoce et à la planification des traitements, tout en favorisant la santé et le bien-être du cerveau. Notre mission repose sur une conviction simple : tout le monde mérite une vie mémorable.

Discover our tools

The MoCA Test

Now the leading screening tool for cognitive impairment associated with Alzheimer’s, dementia, and many other conditions, the MoCA Test was originally developed by Dr. Ziad Nasreddine, a cognitive neurologist seeking a faster, more accurate way to assess multiple cognitive domains in his patients. After several iterations, the MoCA Test was validated in 2005 and has since been adapted into over 100 languages and specialized clinical applications.

In under 15 minutes, the 30-point tool evaluates key cognitive domains such as executive function, memory, language, attention, and visuospatial skills through 13 tasks based on validated neuropsychological constructs.

Learn more about our paper tests

Today, the MoCA Test is included in clinical guidelines and toolkits worldwide. The 2021 World Alzheimer Report identified MoCA as the most widely used tool for detecting mild cognitive impairment (MCI), and a 2023 global Delphi consensus ranked it the #1 test among 53 tools for early Alzheimer’s detection (Ellison et al., 2023).

MoCA empowers healthcare professionals and researchers to detect cognitive impairment related to:

Alzheimer’s disease

Parkinson’s disease

Fronto-temporal dementia

Lewy Body Dementia

VCI/Stroke

Dozens of other conditions

Product

XpressO by MoCA: Try our new self testing tool for the general public.

Learn more

Product

MoCA DUO: Now available for all healthcare professionals.

Learn more

Training

MoCA Certification: Successful completion of 1-hour training is required to administer paper-based MoCA.

Get certified

MoCA Talks

MoCA Talk #23 - Médecine pilotée par les données : comment l'IA façonne l'avenir de la santé cognitive.

Réservez votre place

Meet MoCA Cognition Founder

As a young person escaping a war-torn nation, Ziad Nasreddine came to North America. About a decade later, he completed medical school at the University of Sherbrooke in Quebec, Canada. Dr. Nasreddine later completed a fellowship in Cognitive Neurology/Neurobehavior at UCLA and became a board-certified Neurologist.

In 1992, during his residency, Dr. Nasreddine recognized the need for a more comprehensive cognitive screening tool that could better serve clinical settings. He began the journey of creating his own, more efficient, and complete test. In 2005, Dr. Nasreddine finished validation of the first version of a more specialized assessment that could directly support hospitals and specialty clinics with high volume of patients: the Montreal Cognitive Assessment—or MoCA.

Along with his continued dedication to patients at his memory clinic, Dr. Nasreddine leads MoCA Cognition, a research and innovation-focused company driven to deliver the next generation of cognitive screening solutions.

Leading early detection of cognitive impairment and Alzheimer’s Disease since 2005